1. Home
  2. ALLR

as 05-22-2024 3:33pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

Founded: 2004 Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 1.8M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 3.5M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -410.14 EPS Growth: N/A
52 Week Low/High: $0.55 - $283.20 Next Earning Date: 05-14-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: